337 related articles for article (PubMed ID: 25797700)
1. VEGFR2 Signaling Prevents Colorectal Cancer Cell Senescence to Promote Tumorigenesis in Mice With Colitis.
Foersch S; Sperka T; Lindner C; Taut A; Rudolph KL; Breier G; Boxberger F; Rau TT; Hartmann A; Stürzl M; Wittkopf N; Haep L; Wirtz S; Neurath MF; Waldner MJ
Gastroenterology; 2015 Jul; 149(1):177-189.e10. PubMed ID: 25797700
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of VEGF induces cellular senescence in colorectal cancer cells.
Hasan MR; Ho SH; Owen DA; Tai IT
Int J Cancer; 2011 Nov; 129(9):2115-23. PubMed ID: 21618508
[TBL] [Abstract][Full Text] [Related]
4. BMI1 and MEL18 Promote Colitis-Associated Cancer in Mice via REG3B and STAT3.
Liu X; Wei W; Li X; Shen P; Ju D; Wang Z; Zhang R; Yang F; Chen C; Cao K; Zhu G; Chen H; Chen L; Sui J; Zhang E; Wu K; Wang F; Zhao L; Xi R
Gastroenterology; 2017 Dec; 153(6):1607-1620. PubMed ID: 28780076
[TBL] [Abstract][Full Text] [Related]
5. Circulating vascular endothelial growth factor receptor 2/pAkt-positive cells as a functional pharmacodynamic marker in metastatic colorectal cancers treated with antiangiogenic agent.
Shin SJ; Hwang JW; Ahn JB; Rha SY; Roh JK; Chung HC
Invest New Drugs; 2013 Feb; 31(1):1-13. PubMed ID: 22539090
[TBL] [Abstract][Full Text] [Related]
6. VEGF receptor signaling links inflammation and tumorigenesis in colitis-associated cancer.
Waldner MJ; Wirtz S; Jefremow A; Warntjen M; Neufert C; Atreya R; Becker C; Weigmann B; Vieth M; Rose-John S; Neurath MF
J Exp Med; 2010 Dec; 207(13):2855-68. PubMed ID: 21098094
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E
Kim HB; Kim M; Park YS; Park I; Kim T; Yang SY; Cho CJ; Hwang D; Jung JH; Markowitz SD; Hwang SW; Yang SK; Lim DS; Myung SJ
Gastroenterology; 2017 Feb; 152(3):616-630. PubMed ID: 27864128
[TBL] [Abstract][Full Text] [Related]
8. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
9. Identification of a microRNA landscape targeting the PI3K/Akt signaling pathway in inflammation-induced colorectal carcinogenesis.
Josse C; Bouznad N; Geurts P; Irrthum A; Huynh-Thu VA; Servais L; Hego A; Delvenne P; Bours V; Oury C
Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(3):G229-43. PubMed ID: 24464560
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor receptor-2 inhibition in experimental murine colitis.
Knod L; Donovan EC; Chernoguz A; Crawford KM; Dusing MR; Frischer JS
J Surg Res; 2013 Sep; 184(1):101-7. PubMed ID: 23688787
[TBL] [Abstract][Full Text] [Related]
11. Colorectal carcinoma cell production of transforming growth factor beta decreases expression of endothelial cell vascular endothelial growth factor receptor 2.
Kuczynski EA; Viloria-Petit AM; Coomber BL
Cancer; 2011 Dec; 117(24):5601-11. PubMed ID: 21692070
[TBL] [Abstract][Full Text] [Related]
12. Expression of Free Fatty Acid Receptor 2 by Dendritic Cells Prevents Their Expression of Interleukin 27 and Is Required for Maintenance of Mucosal Barrier and Immune Response Against Colorectal Tumors in Mice.
Lavoie S; Chun E; Bae S; Brennan CA; Gallini Comeau CA; Lang JK; Michaud M; Hoveyda HR; Fraser GL; Fuller MH; Layden BT; Glickman JN; Garrett WS
Gastroenterology; 2020 Apr; 158(5):1359-1372.e9. PubMed ID: 31917258
[TBL] [Abstract][Full Text] [Related]
13. Tumor Necrosis Factor Ligand-Related Molecule 1A Regulates the Occurrence of Colitis-Associated Colorectal Cancer.
Niu W; Wu Z; Wang J; Zhang H; Jia W; Yang M; Luo Y; Zhang X
Dig Dis Sci; 2018 Sep; 63(9):2341-2350. PubMed ID: 29796912
[TBL] [Abstract][Full Text] [Related]
14. 15-Lipoxygenase-1 suppression of colitis-associated colon cancer through inhibition of the IL-6/STAT3 signaling pathway.
Mao F; Xu M; Zuo X; Yu J; Xu W; Moussalli MJ; Elias E; Li HS; Watowich SS; Shureiqi I
FASEB J; 2015 Jun; 29(6):2359-70. PubMed ID: 25713055
[TBL] [Abstract][Full Text] [Related]
15. MyD88 adaptor-like (Mal) regulates intestinal homeostasis and colitis-associated colorectal cancer in mice.
Aviello G; Corr SC; Johnston DG; O'Neill LA; Fallon PG
Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(9):G769-78. PubMed ID: 24603458
[TBL] [Abstract][Full Text] [Related]
16. Glucose-regulated protein 78 silencing down-regulates vascular endothelial growth factor/vascular endothelial growth factor receptor 2 pathway to suppress human colon cancer tumor growth.
Kuo LJ; Hung CS; Chen WY; Chang YJ; Wei PL
J Surg Res; 2013 Nov; 185(1):264-72. PubMed ID: 23759331
[TBL] [Abstract][Full Text] [Related]
17. Pien Tze Huang inhibits tumor angiogenesis in a mouse model of colorectal cancer via suppression of multiple cellular pathways.
Shen A; Lin J; Chen Y; Lin W; Liu L; Hong Z; Sferra TJ; Peng J
Oncol Rep; 2013 Oct; 30(4):1701-6. PubMed ID: 23843018
[TBL] [Abstract][Full Text] [Related]
18. Smad7 expression in T cells prevents colitis-associated cancer.
Rizzo A; Waldner MJ; Stolfi C; Sarra M; Fina D; Becker C; Neurath MF; Macdonald TT; Pallone F; Monteleone G; Fantini MC
Cancer Res; 2011 Dec; 71(24):7423-32. PubMed ID: 22028324
[TBL] [Abstract][Full Text] [Related]
19. Chemopreventive effect of dietary glutamine on colitis-associated colon tumorigenesis in mice.
Tian Y; Wang K; Wang Z; Li N; Ji G
Carcinogenesis; 2013 Jul; 34(7):1593-600. PubMed ID: 23471883
[TBL] [Abstract][Full Text] [Related]
20. Wogonoside prevents colitis-associated colorectal carcinogenesis and colon cancer progression in inflammation-related microenvironment via inhibiting NF-κB activation through PI3K/Akt pathway.
Sun Y; Zhao Y; Wang X; Zhao L; Li W; Ding Y; Kong L; Guo Q; Lu N
Oncotarget; 2016 Jun; 7(23):34300-15. PubMed ID: 27102438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
